iGb3: To be or not to be?

Nature Reviews Immunology

Volumn 7, Issue 5, 2007, Pages 325-

  Ahmad, Sharon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GLYCOSPHINGOLIPID; GLYCOSPHINGOLIPID IGB3; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR IMMUNITY; DENDRITIC CELL; EXPERIMENTAL MOUSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MAMMAL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPECIES; THYMUS; TISSUE DISTRIBUTION;

EID: 34247553691     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2082     Document Type: Article

References (2)

1. Speak, A. O. et al. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobo trihexosylceramide in mammals. Proc. Natl Acad. Sci. USA 19 March 2007 (doi:10.1073/pnas. 0607285104)
2. Porubsky, S. et al. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceram ide (iGb3) deficiency. Proc. Natl Acad. Sci. USA 19 March 2007 (doi: 10.1073/pnas.0611139104)